PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23031158
Abstract: In the past two decades, extensive efforts have been made to develop agents targeting prostate-specific membrane antigen (PSMA) for prostate cancer imaging and therapy. To date, represented by two recent approvals of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL… read more here.
Keywords: targeting imaging; prostate cancer; theranostic agents; imaging theranostic ... See more keywords